AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Metformin Hydrochloride; Glimepiride in Nigeria
10 products registered with NAFDAC — 10 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Co-Mepiryl Tablet 2 mg/500 mg** Tablet | A4-2825 | May & Baker Nigeria PLC | active | 30 Jul 2029 |
| Co-Mepiryl Forte Tablet** Tablet | B4-6590 | May & Baker Nigeria PLC | active | 30 Jul 2029 |
| Perglim M-2 Forte Tablets Prolonged-release tablet | B4-7365 | Mega Lifesciences Nigeria Limited | active | 27 Mar 2028 |
| Glepid Plus Tablet Tablet | B4-6887 | Seal Healthcare Limited | active | 27 Mar 2028 |
| Perglim M-2 Tablets Tablet | A4-1903 | Mega Lifesciences Nigeria Limited | active | 27 Mar 2028 |
| Diapride Plus Tablets** Tablet | A4-5840 | Micro Nova Pharmaceuticals Ind Ltd | active | 25 Aug 2026 |
| Glavamet Tablets** Tablet | C4-1671 | Evans Therapeutics Limited | active | 28 Mar 2026 |
| Suphage Tablet Tablet | B4-3759 | Superior Pharmaceuticals Limited | active | 28 Mar 2026 |
| Zalvax M2 Tablets** Tablet | B4-3223 | Root Drugs Nigeria Limited | active | 27 Jan 2026 |
| Metformin Hydrochloride 500 mg & Glimepiride 2 mg Tablet Tablet | C4-1280 | Brent Cross Pharmaceutical Co. Limited | active | 29 Nov 2025 |
Metformin Hydrochloride; Glimepiride — NAFDAC Registration Details
NAFDAC (Nigeria) has 10 registered products containing Metformin Hydrochloride; Glimepiride, of which 10 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Metformin Hydrochloride; Glimepiride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.